The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Abstract
Stress is a primary risk factor for several neuropsychiatric disorders. Evidence from preclinical models and clinical studies of depression have revealed an array of structural and functional maladaptive changes, whereby adverse environmental factors shape the brain. These changes, observed from the molecular and transcriptional levels through to large-scale brain networks, to the behaviours reveal a complex matrix of interrelated pathophysiological processes that differ between sexes, providing insight into the potential underpinnings of the sex bias of neuropsychiatric disorders. Although many preclinical studies use chronic stress protocols, long-term changes are also induced by acute exposure to traumatic stress, opening a path to identify determinants of resilient versus susceptible responses to both acute and chronic stress. Epigenetic regulation of gene expression has emerged as a key player underlying the persistent impact of stress on the brain. Indeed, histone modification, DNA methylation and microRNAs are closely involved in many aspects of the stress response and reveal the glutamate system as a key player. The success of ketamine has stimulated a whole line of research and development on drugs directly or indirectly targeting glutamate function. However, the challenge of translating the emerging understanding of stress pathophysiology into effective clinical treatments remains a major challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The duration and pattern of stress exposure dictate fundamentally divergent biological outcomes [1,2].”
From Comparative Analysis of HPA-Axis Dysregulation and Dynamic Molecular Mechanisms in Acute Versus Chronic Social Defeat Stress (2025) · cites this paper as [2]
In the citing paper
“Achieving a state of dynamic synaptic homeostasis is essential for normal brain functioning and adaptation to new experiences”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [3]
In the citing paper
“one of the most well-defined brain hallmarks of chronic hyperactivation of the HPA axis and chronic elevation of glucocorticoids is damage to excitatory synapses [16].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [16]
Citations
Cites
Items 201–256 of 256
Komatsuzaki, Y., Hatanaka, Y., Murakami, G., Mukai, H., Hojo, Y., Saito, M., Kimoto, T., & Kawato, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034124 · Cited by 67
NR3C1 hypermethylation in depressed and bullied adolescents
Efstathopoulos, P., Andersson, F., Melas, P. A., Yang, L. L., Villaescusa, J. C., Rȕegg, J., Ekström, T. J., Forsell, Y., Galanti, M. R., & Lavebratt, C. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0169-8 · Cited by 67
Zhu, Y., Strachan, E., Fowler, E., Bacus, T., Roy-Byrne, P., & Zhao, J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0550-2 · Cited by 66
Wei, J., Zhong, P., Qin, L., Tan, T., & Yan, Z. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhx104 · Cited by 65
Self-citationMallei, A., Baj, G., Ieraci, A., Corna, S., Musazzi, L., Lee, F. S., Tongiorgi, E., & Popoli, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv069 · Cited by 62
Self-citationRole of MicroRNAs in Anxiety and Anxiety-Related Disorders
Murphy, C. P., & Singewald, N. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_109 · Cited by 62
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V. D., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · NORA - Norwegian Open Research Archives · Cited by 61
Jochems, J., Teegarden, S. L., Chen, Y., Boulden, J., Challis, C., Ben-Dor, G. A., Kim, S. F., & Berton, O. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.036 · Cited by 58
Wei, J., Xiong, Z., Lee, J. B., Cheng, J., Duffney, L. J., Matas, E., & Yan, Z. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3056-15.2016 · Cited by 56
Self-citationNava, N., Treccani, G., Alabsi, A., Kaastrup Mueller, H., Elfving, B., Popoli, M., Wegener, G., & Nyengaard, J. R. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv254 · Cited by 55
Self-citationWu, Y., Satkunendrarajah, K., & Fehlings, M. G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.059 · Cited by 54
Barbier, E., Johnstone, A. L., Khomtchouk, B. B., Tapocik, J. D., Pitcairn, C., Rehman, F., Augier, E., Borich, A., Schank, J. R., Rienas, C. A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.131 · Cited by 54
Group II metabotropic glutamate receptor blockade promotes stress resilience in mice
Highland, J. N., Zanos, P., Georgiou, P., & Gould, T. D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0380-1 · Cited by 54
Kraus, C., Mkrtchian, A., Kadriu, B., Nugent, A. C., Zarate, C. A., & Evans, J. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0624-0 · Cited by 54
Moench, K. M., Breach, M. R., & Wellman, C. L. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100147 · Cited by 53
Histone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex
Lee, J. B., Wei, J., Liu, W., Cheng, J., Feng, J., & Yan, Z. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224907 · Cited by 52
Self-citationMusazzi, L., Tornese, P., Sala, N., & Popoli, M. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.175 · Cited by 52
Self-citationThe role of eEF2 kinase in the rapid antidepressant actions of ketamine
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.005 · Cited by 52
Musazzi, L., Milanese, M., Farisello, P., Zappettini, S., Tardito, D., Barbiero, V. S., Bonifacino, T., Mallei, A., Baldelli, P., Racagni, G., et al. (2010) · PLoS ONE · doi:10.1371/annotation/101dd9d3-4e1b-4863-9473-bbfef49c9a1d · Cited by 52
Self-citationPapilloud, A., Veenit, V., Tzanoulinou, S., Riccio, O., Zanoletti, O., de Suduiraut, I. G., Grosse, J., & Sandi, C. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0110-0 · Cited by 50
Mokhtari, Z., Baluchnejadmojarad, T., Nikbakht, F., Mansouri, M., & Roghani, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.067 · Cited by 48
Mathew, S. J., Gueorguieva, R. V., Brandt, C., Fava, M., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.106 · Cited by 47
Self-citationGenome-wide association study and polygenic risk score analysis of esketamine treatment response
Li, Q. S., Wajs, E., Ochs-Ross, R., Singh, J., & Drevets, W. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-69291-6 · Cited by 46
Differences between ketamine’s short-term and long-term effects on brain circuitry in depression
Gass, N., Becker, R., Reinwald, J., Cosa‐Linan, A., Sack, M., Weber‐Fahr, W., Vollmayr, B., & Sartorius, A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0506-6 · Cited by 45
Daws, S. E., Jamieson, S., de Nijs, L., Jones, M., Snijders, C., Klengel, T., Joseph, N. F., Krauskopf, J., Kleinjans, J., Vinkers, C. H., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0432-2 · Cited by 44
Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature
Srinivas, S., Wali, A. R., & Pham, M. H. (2019) · Neurosurgical FOCUS · doi:10.3171/2019.1.focus18596 · Cited by 43
Cohen, S., Matar, M. A., Vainer, E., Zohar, J., Kaplan, Z., & Cohen, H. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0698-9 · Cited by 43
Stress, trauma and PTSD: translational insights into the core synaptic circuitry and its modulation
Bennett, M. R., Hatton, S. N., & Lagopoulos, J. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1056-1 · Cited by 41
Lesuis, S. L., Kaplick, P. M., Lucassen, P. J., & Krugers, H. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.023 · Cited by 41
Elhussiny, M. E. A., Carini, G., Mingardi, J., Tornese, P., Sala, N., Bono, F., Fiorentini, C., La Via, L., Popoli, M., Musazzi, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110033 · Cited by 41
Self-citationMallei, A., Ieraci, A., & Popoli, M. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1500029 · Cited by 38
Self-citationRapid acting antidepressants in the mTOR pathway: Current evidence
Athira, K. V., Mohan, A. S., & Chakravarty, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.022 · Cited by 38
Arnau-Soler, A., Adams, M. J., Scotland, G., Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Hayward, C., & Thomson, P. A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209160 · Cited by 35
Nava, N., Treccani, G., Liebenberg, N., Chen, F., Popoli, M., Wegener, G., & Nyengaard, J. R. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu085 · Cited by 32
Self-citationAbdallah, C. G., Ahn, K.-H., Averill, L. A., Nemati, S., Averill, C. L., Fouda, S., Ranganathan, M., Morgan, P. T., D’Souza, D. C., Mathalon, D. H., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00864-9 · Cited by 32
Tetreault, L. A., Zhu, M. P., Wilson, J. R., Karadimas, S. K., & Fehlings, M. G. (2019) · Global Spine Journal · doi:10.1177/2192568219835516 · Cited by 31
Vogel Ciernia, A., Laufer, B. I., Dunaway, K. W., Mordaunt, C. E., Coulson, R. L., Totah, T. S., Stolzenberg, D. S., Frahm, J. C., Singh-Taylor, A., Baram, T. Z., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1451720 · Cited by 28
Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders
Alam, M. A., & Datta, P. K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01510 · Cited by 26
Wei, J., Cheng, J., Waddell, N. J., Wang, Z.-J., Pang, X., Cao, Q., Liu, A., Chitaman, J. M., Abreu, K., Jasrotia, R. S., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa337 · Cited by 26
Self-citationShen, X., Yuan, H., Wang, G., Xue, H., Liu, Y., & Zhang, C.-X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.062 · Cited by 24
Early life stress alters transcriptomic patterning across reward circuitry in male and female micePreprint
Peña, C. J., Smith, M. R., Ramakrishnan, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/624353 · Cited by 24
McIntosh, A. L., Gormley, S., Tozzi, L., Frodl, T., & Harkin, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00150 · Cited by 23
Kerckhove, N., Busserolles, J., Stanbury, T., Pereira, B., Plence, V., Bonnetain, F., Krakowski, I., Eschalier, A., Pezet, D., & Balayssac, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027770 · Cited by 22
Spangler, P. T., West, J. C., Dempsey, C. L., Possemato, K., Bartolanzo, D., Aliaga, P. A., Zarate, C. A., Vythilingam, M., & Benedek, D. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13233 · Cited by 21
Electric foot shock stress adaptation: Does it exist or not?
Bali, A., & Jaggi, A. S. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.004 · Cited by 20
Prophylactic Riluzole Attenuates Oxidative Stress Damage in Spinal Cord Distraction
Shimizu, E. N., Seifert, J. L., Johnson, K. J., & Romero‐Ortega, M. I. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5494 · Cited by 20
Longer-term open-label study of adjunctive riluzole in treatment-resistant depression
Sakurai, H., Dording, C., Yeung, A., Foster, S., Jain, F., Chang, T., Trinh, N.-H., Bernard, R., Boyden, S., Iqbal, S. Z., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.065 · Cited by 20
Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
Chaki, S., Koike, H., & Fukumoto, K. (2019) · Chronic Stress · doi:10.1177/2470547019837712 · Cited by 19
Joffe, M. E., & Conn, P. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0192-8 · Cited by 17
Yao, R., Wang, H., Yuan, M., Wang, G., & Wu, C. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112750 · Cited by 16
Is riluzole a new drug for Alzheimer's disease?
Whitcomb, D. J., & Molnár, E. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13260 · Cited by 12
Azim, L., Hindmarch, P. N., Browne, G., Chadwick, T. J., Clare, E., Courtney, P., Dixon, L., Duffelen, N., Fouweather, T., Geddes, J. R., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03322-y · Cited by 10
Homiack, D., O’Cinneide, E. M., Hajmurad, S., Dohanich, G. P., & Schrader, L. A. (2018) · Stress · doi:10.1080/10253890.2018.1484099 · Cited by 9
microRNA regulation of persistent stress-enhanced memoryPreprint
Sillivan, S. E., Jamieson, S., de Nijs, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/379594 · Cited by 7
Ciernia, A. V., Laufer, B. I., Dunaway, K. W., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/191791 · Cited by 2
Abdallah, C. G., Ahn, K.-H., Averill, L. A., et al. (2020) · medRxiv · doi:10.1101/2020.04.10.20061085 · Cited by 1
Research works printed but not linked: 1
- Selye, H. The general adaptation syndrome and the diseases of adaptation. J. Allergy 6, 117–230 (1946).
Cited by
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Self-citationCui, J., Li, M., Wei, Y., Li, H., He, X., Yang, Q., Li, Z., Duan, J., Wu, Z., Chen, Q., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.860043 · Cited by 163
Nicosia, N., Giovenzana, M., Misztak, P., Mingardi, J., & Musazzi, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126521 · Cited by 135
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Yang, S., Wang, J.-J., Cheng, P., Chen, L.-X., Hu, J., & Zhu, G. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01022-1 · Cited by 132
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01728-8 · Cited by 103
Metadata
- Authors
- Sanacora, G., Yan, Z., & Popoli, M.
- Affiliations
- Yale University (US)
- University at Buffalo, State University of New York (US)
- University of Milan (IT)
- Corresponding author
- Popoli, Maurizio
- Venue
- Nature Reviews Neuroscience
- Published
- 2021-12-10
- Volume
- 23
- Issue
- 2
- Pages
- 86-103
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W4200200347
- Cited by
- 197
- References
- 252
- Citations by year
- 2026: 39 · 2025: 50 · 2024: 47 · 2023: 39 · 2022: 22
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- stress, depression, neuropsychiatric disorders, chronic stress, sex differences, epigenetic regulation, histone modifications, DNA methylation, microRNA, glutamatergic system, ketamine, stress resilience, neuroplasticity
- MeSH terms
- Animals, Mental Disorders, Brain, Humans, Nervous System Diseases, Stress, Psychological, Synapses, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.